Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3199 |
|
| Actual shortage: | 254 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2934 (92%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
24 (9%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2021-03-18 | 2021-04-21 | 135971 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2022-10-17 | 2023-10-19 | 172024 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2023-06-20 | 2023-07-05 | 195903 |
| TEVA-PIROXICAM | 20MG | CAPSULE | Resolved | 2023-10-19 | 2024-02-15 | 207435 |
| TEVA-PIROXICAM | 10MG | CAPSULE | Resolved | 2025-06-19 | 2025-09-02 | 260621 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2017-03-13 | 2017-12-16 | 1784 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2017-03-13 | 2018-03-13 | 1787 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2017-04-03 | 2018-02-21 | 5219 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2017-05-10 | 2018-02-21 | 9799 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2017-05-23 | 2018-02-21 | 10896 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2017-05-23 | 2018-02-21 | 10899 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2018-03-13 | 2018-05-30 | 42565 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2019-06-13 | 2019-12-19 | 86611 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2019-06-13 | 2019-07-16 | 86617 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2019-08-22 | 2019-11-08 | 92209 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2019-08-22 | 2020-01-17 | 92215 |
| TEVA-PRAVASTATIN | 10MG | TABLET | Resolved | 2019-09-26 | 2019-12-19 | 94843 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2019-09-26 | 2020-08-21 | 94858 |
| TEVA-PRAVASTATIN | 20MG | TABLET | Resolved | 2019-09-26 | 2020-01-17 | 94867 |
| TEVA-PRAVASTATIN | 40MG | TABLET | Resolved | 2020-01-17 | 2020-08-21 | 103510 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LORAZEPAM | 1MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258513 |
| TEVA-LOSARTAN/HCTZ | 100MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133896 |
| TEVA-LOSARTAN/HCTZ | 100MG 25MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133899 |
| TEVA-LOSARTAN/HCTZ | 50.0MG 12.5MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133902 |
| TEVA-MEDROXYPROGESTERONE | 2.5MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256113 |
| TEVA-MEDROXYPROGESTERONE | 5MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256116 |
| TEVA-MEDROXYPROGESTERONE | 10MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256119 |
| TEVA-METFORMIN | 850MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258449 |
| TEVA-METFORMIN | 500MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258452 |
| TEVA-METOPROLOL | 50MG | TABLET | Discontinued | 2020-07-10 | 2020-07-10 | 119976 |
| TEVA-METOPROLOL | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258537 |
| TEVA-METOPROLOL | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258568 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133908 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2024-10-11 | 2024-10-11 | 240081 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2025-03-20 | 2025-03-20 | 253165 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258532 |
| TEVA-MIRTAZAPINE | 30MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258535 |
| TEVA-MODAFINIL | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258732 |
| TEVA-NAPROXEN | 250MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14055 |
| TEVA-NAPROXEN | 375MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258493 |